These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

955 related items for PubMed ID: 26599135

  • 1. Frontal fasciculi and psychotic symptoms in antipsychotic-naive patients with schizophrenia before and after 6 weeks of selective dopamine D2/3 receptor blockade.
    Ebdrup BH, Raghava JM, Nielsen MØ, Rostrup E, Glenthøj B.
    J Psychiatry Neurosci; 2016 Mar; 41(2):133-41. PubMed ID: 26599135
    [Abstract] [Full Text] [Related]

  • 2. Abnormal white matter microstructure in drug-naive first episode schizophrenia patients before and after eight weeks of antipsychotic treatment.
    Zeng B, Ardekani BA, Tang Y, Zhang T, Zhao S, Cui H, Fan X, Zhuo K, Li C, Xu Y, Goff DC, Wang J.
    Schizophr Res; 2016 Apr; 172(1-3):1-8. PubMed ID: 26852402
    [Abstract] [Full Text] [Related]

  • 3. Frontal D2/3 Receptor Availability in Schizophrenia Patients Before and After Their First Antipsychotic Treatment: Relation to Cognitive Functions and Psychopathology.
    Nørbak-Emig H, Ebdrup BH, Fagerlund B, Svarer C, Rasmussen H, Friberg L, Allerup PN, Rostrup E, Pinborg LH, Glenthøj BY.
    Int J Neuropsychopharmacol; 2016 May; 19(5):. PubMed ID: 26819282
    [Abstract] [Full Text] [Related]

  • 4. Effects of Blocking D2/D3 Receptors on Mismatch Negativity and P3a Amplitude of Initially Antipsychotic Naïve, First Episode Schizophrenia Patients.
    Düring S, Glenthøj BY, Oranje B.
    Int J Neuropsychopharmacol; 2015 Oct 09; 19(3):pyv109. PubMed ID: 26453696
    [Abstract] [Full Text] [Related]

  • 5. Subtle white matter alterations in schizophrenia identified with a new measure of fiber density.
    Stämpfli P, Sommer S, Manoliu A, Burrer A, Schmidt A, Herdener M, Seifritz E, Kaiser S, Kirschner M.
    Sci Rep; 2019 Mar 15; 9(1):4636. PubMed ID: 30874571
    [Abstract] [Full Text] [Related]

  • 6. Baseline symptom-related white matter tracts predict individualized treatment response to 12-week antipsychotic monotherapies in first-episode schizophrenia.
    Chen Y, Liu S, Zhang B, Zhao G, Zhang Z, Li S, Li H, Yu X, Deng H, Cao H.
    Transl Psychiatry; 2024 Jan 13; 14(1):23. PubMed ID: 38218952
    [Abstract] [Full Text] [Related]

  • 7. Striatal D(2/3) Binding Potential Values in Drug-Naïve First-Episode Schizophrenia Patients Correlate With Treatment Outcome.
    Wulff S, Pinborg LH, Svarer C, Jensen LT, Nielsen MØ, Allerup P, Bak N, Rasmussen H, Frandsen E, Rostrup E, Glenthøj BY.
    Schizophr Bull; 2015 Sep 13; 41(5):1143-52. PubMed ID: 25698711
    [Abstract] [Full Text] [Related]

  • 8. Effects of dopamine D2/D3 blockade on human sensory and sensorimotor gating in initially antipsychotic-naive, first-episode schizophrenia patients.
    Düring S, Glenthøj BY, Andersen GS, Oranje B.
    Neuropsychopharmacology; 2014 Dec 13; 39(13):3000-8. PubMed ID: 24954063
    [Abstract] [Full Text] [Related]

  • 9. Analysis of white matter characteristics with tract-based spatial statistics according to diffusion tensor imaging in early Parkinson's disease.
    Li XR, Ren YD, Cao B, Huang XL.
    Neurosci Lett; 2018 May 14; 675():127-132. PubMed ID: 29199095
    [Abstract] [Full Text] [Related]

  • 10. Extrastriatal dopamine D2/3 receptors and cortical grey matter volumes in antipsychotic-naïve schizophrenia patients before and after initial antipsychotic treatment.
    Nørbak-Emig H, Pinborg LH, Raghava JM, Svarer C, Baaré WFC, Allerup P, Friberg L, Rostrup E, Glenthøj B, Ebdrup BH.
    World J Biol Psychiatry; 2017 Oct 14; 18(7):539-549. PubMed ID: 27782768
    [Abstract] [Full Text] [Related]

  • 11. Prolactinemia is uncoupled from central D2/D3 dopamine receptor occupancy in amisulpride treated patients.
    Bressan RA, Erlandsson K, Spencer EP, Ell PJ, Pilowsky LS.
    Psychopharmacology (Berl); 2004 Sep 14; 175(3):367-73. PubMed ID: 14997280
    [Abstract] [Full Text] [Related]

  • 12. White-matter microstructure in previously drug-naive patients with schizophrenia after 6 weeks of treatment.
    Wang Q, Cheung C, Deng W, Li M, Huang C, Ma X, Wang Y, Jiang L, Sham PC, Collier DA, Gong Q, Chua SE, McAlonan GM, Li T.
    Psychol Med; 2013 Nov 14; 43(11):2301-9. PubMed ID: 23442742
    [Abstract] [Full Text] [Related]

  • 13. Gray and white matter changes and their relation to illness trajectory in first episode psychosis.
    Keymer-Gausset A, Alonso-Solís A, Corripio I, Sauras-Quetcuti RB, Pomarol-Clotet E, Canales-Rodriguez EJ, Grasa-Bello E, Álvarez E, Portella MJ.
    Eur Neuropsychopharmacol; 2018 Mar 14; 28(3):392-400. PubMed ID: 29338891
    [Abstract] [Full Text] [Related]

  • 14. Effect of clozapine on white matter integrity in patients with schizophrenia: a diffusion tensor imaging study.
    Ozcelik-Eroglu E, Ertugrul A, Oguz KK, Has AC, Karahan S, Yazici MK.
    Psychiatry Res; 2014 Sep 30; 223(3):226-35. PubMed ID: 25012780
    [Abstract] [Full Text] [Related]

  • 15. State-dependent microstructural white matter changes in drug-naïve patients with first-episode psychosis.
    Serpa MH, Doshi J, Erus G, Chaim-Avancini TM, Cavallet M, van de Bilt MT, Sallet PC, Gattaz WF, Davatzikos C, Busatto GF, Zanetti MV.
    Psychol Med; 2017 Nov 30; 47(15):2613-2627. PubMed ID: 28826419
    [Abstract] [Full Text] [Related]

  • 16. White matter microstructural organizations in patients with severe treatment-resistant schizophrenia: A diffusion tensor imaging study.
    Ochi R, Noda Y, Tsuchimoto S, Tarumi R, Honda S, Matsushita K, Tsugawa S, Plitman E, Masuda F, Ogyu K, Wada M, Miyazaki T, Fujii S, Chakravarty MM, Graff-Guerrero A, Uchida H, Mimura M, Nakajima S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jun 08; 100():109871. PubMed ID: 31962187
    [Abstract] [Full Text] [Related]

  • 17. Amisulpride a selective dopamine antagonist and atypical antipsychotic: results of a meta-analysis of randomized controlled trials.
    Leucht S.
    Int J Neuropsychopharmacol; 2004 Mar 08; 7 Suppl 1():S15-20. PubMed ID: 14972080
    [Abstract] [Full Text] [Related]

  • 18. Abnormalities in brain white matter in adolescents with 22q11.2 deletion syndrome and psychotic symptoms.
    Kikinis Z, Cho KIK, Coman IL, Radoeva PD, Bouix S, Tang Y, Eckbo R, Makris N, Kwon JS, Kubicki M, Antshel KM, Fremont W, Shenton ME, Kates WR.
    Brain Imaging Behav; 2017 Oct 08; 11(5):1353-1364. PubMed ID: 27730479
    [Abstract] [Full Text] [Related]

  • 19. Impaired empathic abilities and reduced white matter integrity in schizophrenia.
    Fujino J, Takahashi H, Miyata J, Sugihara G, Kubota M, Sasamoto A, Fujiwara H, Aso T, Fukuyama H, Murai T.
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan 03; 48():117-23. PubMed ID: 24099786
    [Abstract] [Full Text] [Related]

  • 20. D2 receptor occupancy during high- and low-dose therapy with the atypical antipsychotic amisulpride: a 123I-iodobenzamide SPECT study.
    la Fougère C, Meisenzahl E, Schmitt G, Stauss J, Frodl T, Tatsch K, Hahn K, Möller HJ, Dresel S.
    J Nucl Med; 2005 Jun 03; 46(6):1028-33. PubMed ID: 15937316
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.